The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 9400356)

Published in Arch Neurol on December 01, 1997

Authors

C E Schwartz1, L Coulthard-Morris, B Cole, T Vollmer

Author Affiliations

1: Frontier Science and Technology Research Foundation Inc., Chestnut Hill, Mass., USA.

Articles by these authors

(truncated to the top 100)

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group. Neurology (1998) 2.52

Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology (2008) 2.49

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39

Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology (1999) 2.14

High frequency of adverse health behaviors in multiple sclerosis. Mult Scler (2008) 1.74

Does multiple sclerosis-associated disability differ between races? Neurology (2006) 1.71

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology (2010) 1.56

Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler (2008) 1.55

Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis (1984) 1.53

Fibreoptic tracheal intubation after placement of the laryngeal tube. Br J Anaesth (2002) 1.52

Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis (1986) 1.47

Validation of the NARCOMS registry: diagnosis. Mult Scler (2007) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Fetal neural graft survival. Lancet (1990) 1.40

How new is new: the late sampling strategy with rapid bacterial screening of platelet concentrates? Vox Sang (2012) 1.40

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler (2009) 1.32

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol (1998) 1.31

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27

Lead content of milks fed to infants--1971-1972. N Engl J Med (1973) 1.18

Disparities in the management of multiple sclerosis-related bladder symptoms. Neurology (2007) 1.18

Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18

Differentiation of species of the Streptococcus bovis/equinus-complex by MALDI-TOF Mass Spectrometry in comparison to sodA sequence analyses. Syst Appl Microbiol (2011) 1.18

Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem (1998) 1.15

Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil (1996) 1.15

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Mult Scler (2007) 1.14

Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin (2010) 1.13

Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis. J Neurosci Nurs (2001) 1.12

Changes in the ascertainment of multiple sclerosis. Neurology (2005) 1.12

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy (2006) 1.11

Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler (2007) 1.10

Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil (1996) 1.08

Antigen detection for the diagnosis of gonorrhea. J Clin Microbiol (1984) 1.08

Effects of prostaglandins E1 and F2-alpha on systemic, pulmonary, and splanchnic circulations in dogs. Am J Physiol (1969) 1.03

Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg (1998) 0.96

Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis (1989) 0.96

Is surgical management compromised in elderly patients with breast cancer? Ann Surg (1997) 0.95

Detection of Mycobacterium tuberculosis in gastric aspirates collected from children: hospitalization is not necessary. Pediatrics (1998) 0.95

EHPC 2010: sharing knowledge on environmental health for risk mitigation. Ecotoxicology (2011) 0.93

The role of cyclic AMP in platelet function. Ann N Y Acad Sci (1971) 0.92

Variable memory profiles in Parkinson's disease. J Clin Exp Neuropsychol (1997) 0.92

The vigil: religion and the search for control in the hospital waiting room. J Health Psychol (1999) 0.92

The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg (1997) 0.91

Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand (2010) 0.90

Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol (1998) 0.89

Prognostic analysis of survival in small breast cancers. J Am Coll Surg (1998) 0.88

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology (2012) 0.87

Anti-MAM antibodies in rheumatic disease: evidence for a MAM-like superantigen in rheumatoid arthritis? J Rheumatol (2000) 0.86

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma. Cancer (1996) 0.86

The influence of two different dental local anaesthetic solutions on the haemodynamic responses of children undergoing restorative dentistry: a randomised, single-blind, split-mouth study. Br Dent J (2001) 0.85

Reducing child hazards in the home. A joint venture in injury control. J Burn Care Rehabil (1990) 0.84

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS. J Neurol (2008) 0.83

Variance and sample size calculations in quality-of-life--adjusted survival analysis (Q-TWiST). Biometrics (2000) 0.83

Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. Am J Surg (1997) 0.82

International Headache Society headache diagnostic patterns in pain facility patients. Clin J Pain (2001) 0.82

Microangiopathic glomerulopathy in children with sickle cell anemia. Pediatr Pathol Lab Med (1997) 0.82

Mutational analysis of two DR alpha residues involved in dimers of HLA-DR molecules. J Immunol (1995) 0.82

Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: a 12-year single-center experience. Surgery (1996) 0.81

Reply to Fr. Ashley. Natl Cathol Bioeth Q (2001) 0.81

Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer. Ann Oncol (2005) 0.80

Diversity of effects of fructose loads on different parts of the nephron. Int J Biochem (1980) 0.79

Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer. J Cancer Res Clin Oncol (1996) 0.79

Identifying patients at risk for loss to follow-up after pain center treatment. Pain Med (2001) 0.79

Molecular oncogene markers and their significance in cutaneous malignant melanoma. Ann Surg Oncol (1998) 0.78

Spectroscopy of the IR transitions in Pr3+ doped heavy metal selenide glasses. Opt Express (1997) 0.78

Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results. Semin Oncol (1997) 0.78

Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation. J Immunol (1995) 0.78

Age and sex modulate effects of stress on the immune system: a multivariate analysis. Int J Neurosci (1994) 0.78

Spore-forming organisms in platelet concentrates: a challenge in transfusion bacterial safety. Transfus Med (2008) 0.77

Measurement of the azimuthal angle dependence of inclusive jet yields in Pb+Pb collisions at √(sNN)=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.77

Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12. Clin Exp Metastasis (1999) 0.77

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression? Mult Scler (2009) 0.77

Coffin-Lowry syndrome and premature tooth loss: a case report. ASDC J Dent Child (2000) 0.76

Cyclic hormonogenesis in gray collie dogs: interactions of hematopoietic and endocrine systems. Endocrinology (1987) 0.76

Modafinil for the treatment of pain-associated fatigue: review and case report. J Pain Palliat Care Pharmacother (2004) 0.76

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. 1998 [classical article]. Neurology (2001) 0.76

DSP-4 treatment influences olfactory preferences of developing rats. Brain Res (1996) 0.76

Pilot study of the behavioral effects of flumazenil in two children with autism. J Autism Dev Disord (2000) 0.76

Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats. Brain Res (1989) 0.75

Model-independent source imaging using two-pion correlations in (2 to 8)a GeV Au+Au collisions. Phys Rev Lett (2001) 0.75

[Palliative psychooncology--demand and methods. Beginning anew at the end?]. Internist (Berl) (2000) 0.75

Attributions for youth crime among British and Nigerian primary school children. J Soc Psychol (1998) 0.75

Near-threshold production of the multistrange Xi- hyperon. Phys Rev Lett (2003) 0.75

Hydrotubation in the management of female infertility: outcome in low resource settings. East Afr Med J (2009) 0.75

Effects of disodium EDTA on the cardiovascular responses to prostaglandin E1. Experientia (1968) 0.75

Effect of tyramine and octopamine on lipolysis in isolated fat cells of the rat. J Pharm Pharmacol (1969) 0.75

Effects of prostaglandins on function and cyclic AMP levels of human blood platelets. Ann N Y Acad Sci (1971) 0.75

Lexical usage of retarded children: an examination of informativeness. Am J Ment Defic (1979) 0.75

The evaluation of imprecision in collaborative immunoassay quality-assessment programmes. Ann Clin Biochem (1984) 0.75

Continuous quality improvement, total quality management, and reengineering: one hospital's continuous quality improvement journey. Am J Med Qual (1998) 0.75

Effectiveness of hypnosis as an adjunct to behavioral weight management. J Clin Psychol (1985) 0.75

Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas. J Neurooncol (1998) 0.75

Longitudinal flow of protons from (2-8)A GeV central Au+Au collisions. Phys Rev Lett (2002) 0.75

Directed flow of lambda hyperons in (2-6 )A GeV Au+Au collisions. Phys Rev Lett (2001) 0.75

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis. Arch Neurol (1997) 0.75

Effect of metaraminol on lipolysis in isolated rat cells. Proc Soc Exp Biol Med (1968) 0.75

Comparison of source images for protons, pi-'s, and lambda's in 6A GeV Au+Au collisions. Phys Rev Lett (2003) 0.75

Insertion of the total artificial heart. IRB (1982) 0.75

Immunologic cross-reaction between HIV type 1 p17 and Mycoplasma hyorhinis variable lipoprotein. AIDS Res Hum Retroviruses (1998) 0.75